Assistant Secretary for Health Admiral Brett P. Giroir, M.D., Statement on FDA EUA Approval of the BD Veritor Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2

July 06, 2020 •

Today, the U.S. Food and Drug Administration granted an Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test BD Veritor Plus System. Read More...